Invention Grant
US07713960B2 Inhibition of the Raf/Mek/P-Erk pathway for treating cancer
有权
抑制Raf / Mek / P-Erk途径治疗癌症
- Patent Title: Inhibition of the Raf/Mek/P-Erk pathway for treating cancer
- Patent Title (中): 抑制Raf / Mek / P-Erk途径治疗癌症
-
Application No.: US11490777Application Date: 2006-07-21
-
Publication No.: US07713960B2Publication Date: 2010-05-11
- Inventor: Said M. Sebti
- Applicant: Said M. Sebti
- Applicant Address: US FL Tampa
- Assignee: University of South Florida
- Current Assignee: University of South Florida
- Current Assignee Address: US FL Tampa
- Agency: Morrison & Foerster LLP
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/435
Abstract:
The invention disclosed herein provides for methods of treating cancer using inhibitors of the Raf/Mek/P-Erk 1/2 pathway. These inhibitors include B2AR agonists (such as ARA-211 (pirbuterol) and isoproterenol), adenylyl cyclase activators, cAMP analogs and Epac activators. The invention also provides methods for diagnosing cancer in an individual.
Public/Granted literature
- US20070021512A1 Inhibition of the Raf/Mek/P-Erk pathway for treating cancer Public/Granted day:2007-01-25
Information query
IPC分类:
